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During January and February 2001, an outbreak of
febrile illness associated with altered sensorium was
observed in Siliguri, West Bengal, India. Laboratory inves-
tigations at the time of the outbreak did not identify an infec-
tious agent. Because Siliguri is in close proximity to
Bangladesh, where outbreaks of Nipah virus (NiV) infection
were recently described, clinical material obtained during
the Siliguri outbreak was retrospectively analyzed for evi-
dence of NiV infection. NiV-specific immunoglobulin M
(IgM) and IgG antibodies were detected in 9 of 18 patients.
Reverse transcription–polymerase chain reaction (RT-
PCR) assays detected RNAfrom NiV in urine samples from
5 patients. Sequence analysis confirmed that the PCR
products were derived from NiV RNA and suggested that
the NiV from Siliguri was more closely related to NiV iso-
lates from Bangladesh than to NiV isolates from Malaysia.
NiV infection has not been previously detected in India. 
D
uring January and February of 2001, an outbreak of
febrile illness with altered sensorium was observed in
Siliguri, West Bengal, India. Siliguri is an important com-
mercial center with a population of ≈500,000. It is near
borders with China, Bangladesh, Nepal, and Sikkim. The
outbreak occurred among hospitalized patients, family
contacts of the patients, and medical staff of 4 hospitals.
Japanese encephalitis, which is endemic in this area, was
initially suspected, but the age group affected and the epi-
demiologic features suggested a different disease.
Laboratory investigations conducted at the time of the out-
break failed to identify an infectious agent (1).
Nipah virus (NiV), a recently emergent, zoonotic
paramyxovirus (2), was implicated as the cause of a high-
ly fatal (case-fatality ratio 38%–75%), febrile human
encephalitis in Malaysia and Singapore in 1999 (1) and in
Bangladesh during the winters of 2001, 2003, and 2004
(3–6). The natural reservoir of NiV is presumed to be fruit
bats of the genus Pteropus. Evidence of NiV infection was
detected in these bats in Malaysia, Bangladesh, and
Cambodia (7–10). In the Malaysian outbreak, NiV was
introduced into the pig population, and most of the human
cases resulted from exposure to ill pigs (2). However, an
intermediate animal host was not identified during the
Bangladesh outbreaks, which suggests that the virus was
transmitted either directly or indirectly from infected bats
to humans. Human-to-human transmission of NiV was
also documented during the outbreak in Faridpur,
Bangladesh (4,5). Because the clinical manifestations of
the cases in Siliguri were similar to those of NiV cases in
Bangladesh (3–6), and because Siliguri is near affected
areas in Bangladesh, a retrospective analysis of clinical
samples was undertaken to determine if NiV was associat-
ed with the Siliguri outbreak. 
Methods
Case Definition and Clinical Sample Collection
A team of physicians and epidemiologists from the
National Institute of Virology, Pune, India, along with
local public health authorities, visited Siliguri.
Investigations were conducted with the assistance of
health authorities from West Bengal State and staff from
the North Bengal Medical College Hospital. Medical
records of patients who were hospitalized during the study
period were examined, and their family members or care-
takers were interviewed. Areas of the town in which cases
occurred and the houses of patients who died were visited.
Contacts and family members of patients who died were
also interviewed.
A broad working case definition was used for case
detection. The case definition evolved over the course of
the outbreak on the basis of information from case-patients
admitted to different hospitals, review of the line list of
patients, and interviews with contacts in the community. A
suspected patient was one >15 years of age with acute
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Blood samples were available for 18 hospitalized patients
and for 13 family contacts of patients who died 2–3 weeks
earlier. Six urine samples (5 samples had corresponding
serum samples) were also collected. 
Serologic Testing
State health authorities conducted laboratory tests to
rule out malaria and bacterial infections. Serologic tests to
detect infection by Japanese encephalitis virus, West Nile
virus, measles virus, dengue virus, Leptospira spp., and
hantavirus were carried out at the National Institute of
Virology.
Serum samples were gamma-irradiated at the Centers
for Disease Control and Prevention (CDC) before being
tested for immunoglobulin G (IgG) and IgM antibodies to
NiV and measles by enzyme-linked immunosorbent assay
(ELISA), as previously described (2,11,12). Briefly, inac-
tivated antigens for these ELISAs were prepared from
gamma (60Co)-irradiated NiV-infected or mock-infected
Vero E6 cells. Serum samples were tested in 4-fold dilu-
tions from 1:100 to 1:6,400. Samples were considered pos-
itive for the IgM assay if the sum of the adjusted optical
densities (OD) from all of the dilutions (OD from infected
antigen well minus OD from the mock-infected antigen)
was >0.75 through the entire dilution series, and the titer
was >1:400. Similarly, samples were considered positive
for IgG if the sum for the adjusted OD from all the dilu-
tions was >0.90 through the entire dilution series, and the
titer was >1:400.
Detection of NiV by RT-PCR and Virus Isolation
RNA was extracted from urine samples by using a
Qiagen (Valencia, CA, USA) RNA extraction kit. Reverse
transcription–polymerase chain reaction (RT-PCR) was
performed with the SuperScript One-Step RT-PCR kit with
Platinum Taq (Invitrogen, Carlsbad, CA, USA), as previ-
ously described (13,14). Reaction products were analyzed
by agarose gel electrophoresis and ethidium bromide
straining. PCR products were sequenced by using a cycle
sequencing reaction with fluorescent dye terminators
(Perkin-Elmer, Applied Biosystems Division, Foster City,
CA, USA), and reaction products were analyzed with an
ABI 3100 (Perkin-Elmer) automatic sequencer. Sequence
data from multiple reactions were analyzed by using ver-
sion 10.1 of the Genetics Computer Group Package
(Accelrys, San Diego, CA, USA). Phylogenetic analyses
were performed with PAUP version 4.01 (Sinauer
Associates, Sunderland, MA, USA). Two sets of primers
were used for RT-PCR reactions. Primer set NVNBF-4 (5′-
GGAGTTATCAATCTAAGTTAG-3′) and NVNBR4 (5′-
CATAGAGATGAGTGTAAAAGC-3′) amplified a 159-
nucleotide (nt) region of the N gene of NiV. Primer set
NVBMFC1 (5′-CAATGGAGCCAGACATCAAGAG-3′)
and NVBMFR2 (5′-CGGAGAGTAGGAGTTCTA-
GAAG-3′) amplified a 320-nt region of the M gene. Virus
isolation was attempted from the urine samples on Vero E6
cells as previously described (2). 
Results
The outbreak of fever with altered sensorium began in
late January 2001 and peaked in mid-February. No cases
were reported after February 23 (Figure 1). All of the
patients were residents of Siliguri, and some clustering of
cases was observed around the Medinova Hospital, since
the staff of this hospital resided in the area. Based on the
case definition, 66 cases of encephalitis were identified,
and the case-fatality ratio was ≈74%. The outcome of 61
cases was known; the remaining 5 patients were dis-
charged from the hospital against medical advice. All
patients were >15 years of age; the male-to-female ratio
was 1.4:1. Forty-five (75%) of the 60 patients had a histo-
ry of hospital exposure, i.e., they were members of the hos-
pital staff or had attended to or visited patients in the
hospital. The outbreak began at a single hospital, and cases
were subsequently detected at 3 other hospitals. No defin-
itive information about the possible index case exists. Five
families had >1 case, but all of the persons affected had a
history of hospital visits and had onset of illness 2 or 3
days apart from each other. The sequence of events is
shown in Figure 2.
The patients initially had fever (100%), headache and
myalgia (57%), vomiting (19%), altered sensorium (confu-
sion to coma, 97%), respiratory symptoms (tachypnea to
acute respiratory distress, 51%), and involuntary move-
ments or convulsions (43%). No neck rigidity or cranial
nerve involvement was observed in the 16 patients who
were examined. Pupils were bilaterally dilated and reactive
to light. Deep tendon reflexes were diminished or absent.
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Figure 1. Epidemic curve of outbreak of febrile encephalitis in
Siliguri, India, January though February 2001, by number of hos-
pital-associated and nonhospital-associated cases and deaths.
The vertical, black arrow indicates when barrier methods were
introduced for case management.Abnormal plantar reflexes (extensor plantar response)
were elicited in 11 patients. Patients were normotensive at
admission but became hypertensive before death. Death
occurred within 1 week of onset of disease in 10 patients
(62.5%), within 2 weeks in 5 (32.8%) patients, and on day
30 after onset for 2 patients. 
Before the outbreak, the staff did not routinely use per-
sonal protective equipment or barrier nursing methods.
Use of surgical masks was minimal on wards, except in the
intensive-care units. Certain universal precautions, such as
hand washing and use of gloves, were partially adhered to
when staff were carrying out invasive procedures. Patients
were housed on wards with >4 patients in a single room
and could be visited or be attended to by their family and
others. Patients did not wear masks on wards or when
being transported for procedures (e.g., x-ray examination).
Disposal of waste, collection of soiled linen, laundry, and
cleaning of floors and other surfaces in the wards were car-
ried out by personnel who did not follow infection control
practices.
Once the outbreak of encephalitis was established,
stringent infection control practices were introduced
(Figure 1), including isolating patients in the Medical
College Hospital, where 2 wards were established, one for
suspected and the other for probable cases. Barrier nursing
techniques were initiated, and housekeeping procedures
and waste management were improved.
Cerebrospinal fluid was obtained from all patients.
Analysis showed that the fluid in all cases was under pres-
sure and clear with <5 lymphocytes/mm3 (normal range
0–5 cells/mm3). These samples were not available for fur-
ther analysis.
Laboratory testing during and immediately after the
outbreak did not identify a likely etiologic agent. Patient
serum samples were tested for IgM antibodies to Japanese
encephalitis, West Nile, dengue, and measles viruses as
well as for Leptospira spp. Serum samples were also test-
ed for IgG antibody to hantavirus. All serologic tests were
negative, and no likely viral or bacterial agents were
detected. All serum samples tested positive for IgG to
measles virus.
Because NiV was identified as the cause of encephali-
tis outbreaks in Bangladesh, the Siliguri samples were test-
ed for evidence of NiV infection. In all, 17 serum samples
were available from 18 patients from Siliguri. All were
tested for IgG and IgM antibodies to NiV by ELISA. The
6 urine samples collected from these 18 patients were test-
ed for NiV RNAby RT-PCR, and aliquots were inoculated
onto Vero E6 cells in an attempt to isolate NiV. 
NiV-specific IgM and IgG were detected in 9 of 17
serum samples; 1 sample was positive for IgG and nega-
tive for IgM (Table). RT-PCR assays detected RNA from
the N gene of NiV in 4 urine samples from NiV
antibody–positive patients and in 1 urine sample from a
NiV antibody–negative patient. RNAfrom the M gene was
detected in 3 of these 5 samples (Table). No viral isolates
were obtained from the 6 urine samples. 
Sequence analysis confirmed that the PCR products
were derived from NiV RNA (Figures 3 and 4). Partial N-
gene sequences (159 nt) from 2 of 5 Siliguri samples were
identical, and the other 3 sequences differed by no more
than 1 nt, although unresolved sequence heterogeneity
occurred at 2 positions (Aor G) in 3 of the Siliguri N-gene
sequences (Figure 3). Comparison of the Siliguri N-gene
sequences to the N-gene sequences from NiV samples iso-
lated in Bangladesh in 2004 and Malaysia in 1999 showed
an overall level of nucleotide identity of 97.5%. Siliguri N-
gene sequences were more closely related to the N-gene
sequence from the Bangladesh isolate than to the
sequences from the Malaysian isolates. Two of the Siliguri
N-gene sequences were identical to the Bangladesh N-
gene sequence. 
Comparison of the partial M gene sequence amplified
from the specimens from Siliguri to the M gene sequences
from NiV isolated in Malaysia and Bangladesh (Figure 4)
showed identity at 302 (94%) of 320 nt positions. Again,
the Siliguri M gene sequences were more closely related to
the M gene sequences from Bangladesh (99% identity)
than to the sequences from Malaysia (94% identity). 
Discussion
This retrospective study provides evidence of NiV
infection during a 2001 outbreak of febrile encephalitis in
Siliguri. Nine of 18 of the patients tested had IgM and IgG
antibodies; 1 had IgG antibodies only to NiV. Urine sam-
ples from 4 of these patients contained NiV RNA. One
other patient had NiV RNA in the urine but lacked a
detectable IgM and IgG response. In this case, the serum
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Figure 2. Sequence of events in the Siliguri (SD) outbreak.sample may have been obtained early in infection before
antibodies to NiV were present. These laboratory results,
along with the observation that the symptoms in the
Siliguri patients were consistent with those described for
patients during NiV outbreaks in Bangladesh and Malaysia
(3–5,15–17), provide strong evidence that NiV caused the
outbreak in Siliguri. Failure to detect evidence of NiV or
NiV-specific antibodies in some patients may have been
due to early sample collection or to inclusion of encephal-
itides of other causes because of the broad case definition.
One patient was IgG-positive but had no detectable IgM,
which suggests past infection by NiV. Unfortunately,
because no case control and population-based studies were
undertaken during this outbreak, interpreting this result is
difficult. 
The main reservoir for NiV is believed to be fruit bats
of the genus Pteropus. NiV was isolated from fruit bats in
Malaysia and Cambodia, and seropositive bats have been
detected in other parts of Southeast Asia (7–10). In the
Malaysian outbreak, commercially raised pigs were
believed to be intermediate hosts. Presumably, the pigs
were infected by virus shed from fruit bats and then trans-
mitted the virus to humans. Although fruit bats with anti-
bodies to NiV were captured in the outbreak areas of
Bangladesh, no intermediate animal host was identified. In
Bangladesh, NiV might have been transmitted to humans
by direct contact with bats or indirectly by contact with
material contaminated by bats. Person-to-person spread
was also noted during the 2004 NiV outbreak in Faridpur,
Bangladesh (4,5). The range of Pteropus giganteus, one of
the flying foxes commonly found in south Asia (18),
includes West Bengal. Therefore, the range of the proposed
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Figure 3. Comparison of partial N-gene nucleotide sequences
obtained from the Siliguri specimens (by patient number, see
Table) to sequences obtained from Nipah virus isolates from
Bangladesh (AY988601) and Malaysia (AF212302, AF376747).
Letters indicate positions that differ from the reference sequence
on the top line, Nipah-malaysia-1. Dots indicate nucleotide identi-
ty. R indicates A or G. natural reservoir for NiV extends into northeastern India,
and since the geographic features of West Bengal are sim-
ilar to those of Bangladesh, environmental circumstances
that favor transmission of NiVto humans would likely also
be found in West Bengal.
Many of the epidemiologic features of the outbreak in
Siliguri were similar to those of the recent NiV outbreaks
in Bangladesh. In Bangladesh, no intermediate animal host
was identified, whereas in Siliguri studies to detect an
intermediate host were not conducted. In Siliguri, no sam-
ples were obtained from local wildlife or domestic ani-
mals. In both outbreaks, transmission occurred in
healthcare settings through contact with infected persons.
In Siliguri, the observation that only adults were affected
supported the nosocomial transmission theory, as the num-
ber of children on the wards of hospitals was minimal.
During infection, NiV is present in respiratory secretions
and urine (19) and in both outbreaks, failure to use person-
al protective equipment probably contributed to the spread
of the virus. Many of the patients had nasogastric tubes
inserted or were intubated, procedures which made expo-
sure to  respiratory secretions more likely. Initiating ade-
quate barrier nursing techniques helped to curtail further
spread of infection.
Sequence analysis of PCR products confirmed NiV
RNA. Unfortunately, no virus was isolated, and only lim-
ited sequence data could be obtained from the available
clinical material. Analysis of the limited sequence data
suggested that the NiV strains associated with the outbreak
were more closely related to NiV isolated in Bangladesh
than to NiV isolated in Malaysia. These data extend the
previous observation that viruses circulating in different
areas have unique genetic signatures (10,14) and suggest
that these strains may have co-evolved within local natural
reservoirs.
To our knowledge, NiV infection has not occurred pre-
viously in India; however, given the proximity of Siliguri
to the areas of Bangladesh that experienced NiV outbreaks
in 2001, 2002, and 2004, the outbreak is not surprising.
Given the distribution of the locally abundant P. giganteus,
the apparent natural reservoir of NiV in this area, out-
breaks of NiV will likely continue to occur in Bangladesh
and northern India. Establishing appropriate surveillance
systems in these areas will be necessary so that NiV out-
breaks can be detected quickly and appropriate control
measures initiated. When NiV infections are suspected,
infection control practices must be strengthened to avoid
outbreaks in hospital settings, as apparently occurred in
Siliguri.
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